We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
Cap. Flow
+$263M
Cap. Flow %
4.63%
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$35.7M
2
MRK icon
Merck
MRK
+$30.3M
3
MSFT icon
Microsoft
MSFT
+$22.4M
4
YUMC icon
Yum China
YUMC
+$17.6M
5
OXY icon
Occidental Petroleum
OXY
+$17.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$36.5M
2
INTC icon
Intel
INTC
+$32.4M
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$17.1M
4
NVR icon
NVR
NVR
+$16.3M
5
DE icon
Deere & Co
DE
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Financials 17.92%
3 Industrials 13.48%
4 Consumer Discretionary 11.28%
5 Healthcare 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLM icon
926
SLM Corp
SLM
$4.58B
$170K ﹤0.01%
15,083
-183,017
-92% -$2M
GPK icon
927
Graphic Packaging
GPK
$3.26B
$168K ﹤0.01%
10,900
– –
SYRS
928
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$167K ﹤0.01%
+1,717
New +$231K
NAVB
929
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$156K ﹤0.01%
21,814
-1,045
-5% -$8.84K
CALA
930
DELISTED
Calithera Biosciences, Inc
CALA
$155K ﹤0.01%
928
– –
RNWK
931
DELISTED
RealNetworks Inc
RNWK
$152K ﹤0.01%
44,553
– –
CRVS icon
932
Corvus Pharmaceuticals
CRVS
$1.1B
$145K ﹤0.01%
+14,026
New +$180K
PDLI
933
DELISTED
PDL BioPharma, Inc.
PDLI
$145K ﹤0.01%
52,800
-200
-0.4% -$614
ARWR icon
934
Arrowhead Research
ARWR
$12.1B
$143K ﹤0.01%
+38,900
New +$145K
EGY icon
935
Vaalco Energy
EGY
$594M
$142K ﹤0.01%
203,397
-28,661
-12% -$22.4K
KTCC icon
936
Key Tronic
KTCC
$40.3M
$142K ﹤0.01%
+20,888
New +$150K
WOW
937
DELISTED
WideOpenWest
WOW
$141K ﹤0.01%
+13,364
New +$157K
HWCC
938
DELISTED
Houston Wire & Cable Company
HWCC
$138K ﹤0.01%
+19,197
New +$116K
NERV icon
939
Minerva Neurosciences
NERV
$188M
$137K ﹤0.01%
+2,838
New +$141K
SNR
940
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$135K ﹤0.01%
17,800
– –
ARAV
941
DELISTED
Aravive, Inc. Common Stock
ARAV
$133K ﹤0.01%
10,044
-2,883
-22% -$37.1K
LSTA icon
942
Lisata Therapeutics
LSTA
$15.2M
$132K ﹤0.01%
2,512
– –
ATYR
943
aTyr Pharma
ATYR
$46.4M
$129K ﹤0.01%
2,636
-758
-22% -$46.6K
NWHM
944
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$129K ﹤0.01%
+10,256
New +$120K
TNTR
945
DELISTED
Tintri, Inc. Common Stock
TNTR
$127K ﹤0.01%
24,854
-2,700
-10% -$12K
TZOO icon
946
Travelzoo
TZOO
$103M
$126K ﹤0.01%
19,483
+8,868
+84% +$60.8K
FOGO
947
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
$125K ﹤0.01%
+10,800
New +$125K
ARQL
948
DELISTED
Arqule Inc
ARQL
$122K ﹤0.01%
74,044
-63,504
-46% -$82.3K
TBCH
949
Turtle Beach Corp
TBCH
$239M
$111K ﹤0.01%
61,226
– –
EFOI icon
950
Energy Focus
EFOI
$18.3M
$106K ﹤0.01%
1,236
-517
-29% -$47.1K
36 37
38
39 40

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q4 2017 Portfolio in Review

As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.

  • Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
  • Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
  • Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
  • Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
  • Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
  • Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.